A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
Public ClinicalTrials.gov record NCT00801853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb Study to Investigate the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients Not Fully Controlled on Current Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A multi-center, Phase IIb, double-blind, randomized, placebo controlled, parallel-group, repeated-dose study in male and female patients with moderate to severe asthma in which patients will be stabilized on AEROVANT then doses of inhaled corticosteroids and LABA will be tapered. The hypothesis is that AEROVANT will improve asthma symptom control and decrease the need for inhaled corticosteroids and LABA, thus improving exacerbation incidence compared to placebo. Incidence of asthma exacerbation is the primary endpoint.
Study identification
- NCT ID
- NCT00801853
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 424 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Feb 2010 (Actual)
- Completion
- Feb 2010 (Actual)
- Last update posted
- Jan 27, 2011
2009 – 2010
United States locations
- U.S. sites
- 38
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pulmonary Associates of Mobile, P.C. | Mobile | Alabama | — | — |
| Allergy and Immunology Associates Ltd | Scottsdale | Arizona | — | — |
| Allergy and Asthma Specialists Medical Group | Huntington Beach | California | — | — |
| Allergy Associates Medical Group Inc. | San Diego | California | — | — |
| Institute of Healthcare Assessment Inc. | San Diego | California | — | — |
| Allergy and Asthma Associates of Santa Clara Valley Research Center | San Jose | California | — | — |
| Allergy and Asthma Clinical Research Inc. | Walnut Creek | California | — | — |
| Colorado Asthma and Allergy Research Centers, P.C. | Centenniel | Colorado | — | — |
| Asthma and Allergy Associates P.C. and Research Center | Colorado Springs | Colorado | — | — |
| National Jewish Health | Denver | Colorado | — | — |
| Florida Center for Asthma and Allergy Research | Miami | Florida | — | — |
| Allergy and Asthma Diagnostic Treatment Center | Tallahassee | Florida | — | — |
| Partners in Asthma and Allergy Care, P.A. | Valrico | Florida | — | — |
| Pulmonary Consultants of North Idaho | Coeur d'Alene | Idaho | — | — |
| Deaconess Clinic Downtown | Evansville | Indiana | — | — |
| Allergy and Clinical Immunology | Bangor | Maine | — | — |
| The Brigham and Womens Hospital Inc. | Boston | Massachusetts | — | — |
| North East Medical Research Associates, Inc | North Dartmouth | Massachusetts | — | — |
| Cardiopulmonary Associates of Missoula | Missoula | Montana | — | — |
| Pulmonary and Allergy Associates | Summit | New Jersey | — | — |
| ENT and Allergy Associates | Newburgh | New York | — | — |
| Wake Forest University | Winston-Salem | North Carolina | — | — |
| Bernstein Clinical Research Center | Cincinnati | Ohio | — | — |
| New Horizons Clinical Research | Cincinnati | Ohio | — | — |
| Allergy, Asthma and Clinical Research Center | Oklahoma City | Oklahoma | — | — |
| IPS Research | Oklahoma City | Oklahoma | — | — |
| Allergy and Asthma Associates/Oak Street Medical P.C. | Eugene | Oregon | — | — |
| Allergy Associates Research Center | Portland | Oregon | — | — |
| Asthma and Allergy Research of New Jersey Inc. | Philadelphia | Pennsylvania | — | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Asthma and Allergy Research Associates, PA | Upland | Pennsylvania | — | — |
| Asthma, Nasal Disease and Allergy Research Center of New England | Providence | Rhode Island | — | — |
| Greenville Pharmaceutical Research | Greenville | South Carolina | — | — |
| Spartanburg Medical Research | Spartanburg | South Carolina | — | — |
| Baylor College of Medicine | Houston | Texas | — | — |
| Allergy and Asthma Research Center, P.A. | San Antonio | Texas | — | — |
| Discovery Clinical Trials, LLC | San Antonio | Texas | — | — |
| Johnston Memorial Hospital | Abingdon | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00801853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2011 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00801853 live on ClinicalTrials.gov.